original_dataset
stringclasses 7
values | instance_id
stringlengths 5
33
| phrase
stringlengths 1
166
| meddra_code
float64 10M
10.1M
⌀ | sct_id
float64 1.4M
571B
⌀ | umls_cui
stringlengths 8
8
⌀ | mapped_meddra_codes
stringlengths 8
62
| mapped_sct_ids
stringlengths 6
66
| single_mapped_meddra_codes
int64 10M
10.1M
| single_mapped_sct_ids
int64 450k
281,801B
|
|---|---|---|---|---|---|---|---|---|---|
TAC2017_ADR | INLYTA.xml_AR46.N1 | anemia | 10,002,034 | null | null | 10002034 | 271737000 | 10,002,034 | 271,737,000 |
TAC2017_ADR | INLYTA.xml_AR47.N1 | hemorrhoids | 10,019,022 | null | null | 10019022 | 70153002 | 10,019,022 | 70,153,002 |
TAC2017_ADR | INLYTA.xml_AR48.N1 | hematuria | 10,018,867 | null | null | 10018867 | 34436003 53298000 | 10,018,867 | 53,298,000 |
TAC2017_ADR | INLYTA.xml_AR49.N1 | tinnitus | 10,043,882 | null | null | 10043882 | 162352007 60862001 | 10,043,882 | 60,862,001 |
TAC2017_ADR | INLYTA.xml_AR51.N1 | glossodynia | 10,018,388 | null | null | 10018388 | 30731004 | 10,018,388 | 30,731,004 |
TAC2017_ADR | INLYTA.xml_AR52.N1 | pulmonary embolism | 10,037,377 | null | null | 10037377 | 59282003 | 10,037,377 | 59,282,003 |
TAC2017_ADR | INLYTA.xml_AR53.N1 | rectal hemorrhage | 10,038,063 | null | null | 10038063 | 12063002 | 10,038,063 | 12,063,002 |
TAC2017_ADR | INLYTA.xml_AR54.N1 | hemoptysis | 10,018,964 | null | null | 10018964 | 6686005 66857006 | 10,018,964 | 66,857,006 |
TAC2017_ADR | INLYTA.xml_AR55.N1 | deep vein thrombosis | 10,051,055 | null | null | 10051055 | 128053003 | 10,051,055 | 128,053,003 |
TAC2017_ADR | INLYTA.xml_AR56.N1 | retinal-vein occlusion | 10,038,907 | null | null | 10038908 10038907 | 46085004 | 10,038,907 | 46,085,004 |
TAC2017_ADR | INLYTA.xml_AR57.N1 | retinal-vein thrombosis | 10,038,908 | null | null | 10038908 10038907 | 46085004 | 10,038,908 | 46,085,004 |
TAC2017_ADR | INLYTA.xml_AR58.N1 | polycythemia | 10,036,051 | null | null | 10036057 10036051 | 109992005 127062003 | 10,036,051 | 109,992,005 |
TAC2017_ADR | INLYTA.xml_AR59.N1 | transient ischemic attack | 10,044,390 | null | null | 10044390 | 266257000 | 10,044,390 | 266,257,000 |
TAC2017_ADR | INLYTA.xml_AR60.N1 | hemoglobin decreased | 10,018,884 | null | null | 10018884 | 165397008 | 10,018,884 | 165,397,008 |
TAC2017_ADR | INLYTA.xml_AR62.N1 | platelets decreased | 10,035,528 | null | null | 10035528 | 415116008 | 10,035,528 | 415,116,008 |
TAC2017_ADR | INLYTA.xml_AR63.N1 | white blood cells decreased | 10,047,942 | null | null | 10047942 | 419188005 | 10,047,942 | 419,188,005 |
TAC2017_ADR | INLYTA.xml_AR66.N1 | hypocalcemia | 10,020,947 | null | null | 10020947 | 5291005 | 10,020,947 | 5,291,005 |
TAC2017_ADR | INLYTA.xml_AR68.N1 | hyperglycemia | 10,020,635 | null | null | 10020635 | 237598005 80394007 | 10,020,635 | 80,394,007 |
TAC2017_ADR | INLYTA.xml_AR72.N1 | hypernatremia | 10,020,679 | null | null | 10041277 10020679 | 39355002 | 10,020,679 | 39,355,002 |
TAC2017_ADR | INLYTA.xml_AR73.N1 | hypoalbuminemia | 10,020,942 | null | null | 10020942 | 119247004 | 10,020,942 | 119,247,004 |
TAC2017_ADR | INLYTA.xml_AR74.N1 | hyperkalemia | 10,020,646 | null | null | 10020646 | 238142003 166689004 14140009 | 10,020,646 | 14,140,009 |
TAC2017_ADR | INLYTA.xml_AR75.N1 | hypoglycemia | 10,020,993 | null | null | 10020993 | 302866003 271327008 | 10,020,993 | 302,866,003 |
TAC2017_ADR | INLYTA.xml_AR76.N1 | hyponatremia | 10,021,036 | null | null | 10005802 10021036 | 89627008 | 10,021,036 | 89,627,008 |
TAC2017_ADR | INLYTA.xml_AR77.N1 | hypophosphatemia | 10,021,058 | null | null | 10021058 | 4996001 | 10,021,058 | 4,996,001 |
TAC2017_ADR | INLYTA.xml_AR78.N1 | hemoglobin increased | 10,018,888 | null | null | 10018888 | 131141003 | 10,018,888 | 131,141,003 |
TAC2017_ADR | INLYTA.xml_AR79.N1 | hypercalcemia | 10,020,583 | null | null | 10005396 10020583 | 166702002 66931009 | 10,020,583 | 66,931,009 |
TAC2017_ADR | INLYTA.xml_AR80.N1 | hypertensive crisis | 10,020,802 | null | null | 10020802 | 706882009 | 10,020,802 | 706,882,009 |
TAC2017_ADR | INLYTA.xml_AR81.N1 | arterial thrombotic events | 10,003,178 | null | null | 10003178 | 65198009 | 10,003,178 | 65,198,009 |
TAC2017_ADR | INLYTA.xml_AR82.N1 | venous thrombotic events | 10,047,249 | null | null | 10047249 | 111293003 | 10,047,249 | 111,293,003 |
TAC2017_ADR | INLYTA.xml_AR83.N1 | fatal | 10,011,906 | null | null | 10011906 | 397709008 268923008 | 10,011,906 | 397,709,008 |
TAC2017_ADR | INLYTA.xml_AR84.N1 | hemorrhagic events | 10,055,798 | null | null | 10015867 10055798 | 131148009 | 10,055,798 | 131,148,009 |
TAC2017_ADR | INLYTA.xml_AR85.N1 | gastrointestinal fistula | 10,017,877 | null | null | 10017877 | 37831005 | 10,017,877 | 37,831,005 |
TAC2017_ADR | INLYTA.xml_AR86.N1 | death | 10,011,906 | null | null | 10011906 | 397709008 268923008 | 10,011,906 | 397,709,008 |
TAC2017_ADR | INLYTA.xml_AR87.N1 | reversible posterior leukoencephalopathy syndrome | 10,071,066 | null | null | 10071066 | 450886002 | 10,071,066 | 450,886,002 |
TAC2017_ADR | INLYTA.xml_AR90.N1 | systolic blood pressure >150 mmhg | 10,005,760 | null | null | 10005760 | 18050000 | 10,005,760 | 18,050,000 |
TAC2017_ADR | INLYTA.xml_AR91.N1 | diastolic blood pressure >100 mmhg | 10,005,739 | null | null | 10005739 | 23154005 | 10,005,739 | 23,154,005 |
TAC2017_ADR | INLYTA.xml_AR92.N1 | blood pressure increases | 10,005,750 | null | null | 10005750 | 24184005 | 10,005,750 | 24,184,005 |
TAC2017_ADR | INLYTA.xml_AR93.N1 | deaths | 10,011,906 | null | null | 10011906 | 397709008 268923008 | 10,011,906 | 397,709,008 |
TAC2017_ADR | INLYTA.xml_AR94.N1 | cerebrovascular accident | 10,008,190 | null | null | 10008190 | 230690007 | 10,008,190 | 230,690,007 |
TAC2017_ADR | INLYTA.xml_AR95.N1 | myocardial infarction | 10,028,596 | null | null | 10051592 10028596 | 394659003 22298006 | 10,028,596 | 22,298,006 |
TAC2017_ADR | INLYTA.xml_AR96.N1 | retinal artery occlusion | 10,038,827 | null | null | 10038827 | 232035005 | 10,038,827 | 232,035,005 |
TAC2017_ADR | INLYTA.xml_AR97.N1 | retinal vein occlusion | 10,038,907 | null | null | 10038923 10038853 10038907 10038908 | 46085004 29555009 | 10,038,923 | 29,555,009 |
TAC2017_ADR | INLYTA.xml_AR98.N1 | retinal vein thrombosis | 10,038,908 | null | null | 10038908 10038907 | 46085004 | 10,038,908 | 46,085,004 |
TAC2017_ADR | INLYTA.xml_AR99.N1 | cerebral hemorrhage | 10,008,111 | null | null | 10008111 | 274100004 | 10,008,111 | 274,100,004 |
TAC2017_ADR | INLYTA.xml_AR100.N1 | lower gastrointestinal hemorrhage | 10,050,953 | null | null | 10050953 | 87763006 | 10,050,953 | 87,763,006 |
TAC2017_ADR | INLYTA.xml_AR101.N1 | melena | 10,027,141 | null | null | 10027141 | 2901004 | 10,027,141 | 2,901,004 |
TAC2017_ADR | INLYTA.xml_AR102.N1 | gastric hemorrhage | 10,017,788 | null | null | 10017788 | 61401005 | 10,017,788 | 61,401,005 |
TAC2017_ADR | INLYTA.xml_AR103.N1 | gastrointestinal fistulas | 10,017,877 | null | null | 10017877 | 37831005 | 10,017,877 | 37,831,005 |
TAC2017_ADR | INLYTA.xml_AR104.N1 | hyperthyroidism | 10,020,850 | null | null | 10020850 | 34486009 | 10,020,850 | 34,486,009 |
TAC2017_ADR | INLYTA.xml_AR106.N1 | seizure | 10,039,906 | null | null | 10039906 | 91175000 | 10,039,906 | 91,175,000 |
TAC2017_ADR | INLYTA.xml_AR107.N1 | lethargy | 10,024,264 | null | null | 10024264 | 214264003 | 10,024,264 | 214,264,003 |
TAC2017_ADR | INLYTA.xml_AR108.N1 | confusion | 10,010,305 | null | null | 10016322 10025482 10013082 10010305 10001854 10012373 | 213257006 367391008 40917007 | 10,010,305 | 40,917,007 |
TAC2017_ADR | INLYTA.xml_AR110.N1 | visual disturbances | 10,047,571 | null | null | 10047571 | 397540003 7973008 | 10,047,571 | 397,540,003 |
TAC2017_ADR | INLYTA.xml_AR111.N1 | neurologic disturbances | 10,060,860 | null | null | 10060860 | 267070008 308921004 | 10,060,860 | 308,921,004 |
TAC2017_ADR | NORTHERA.xml_AR1.N1 | supine hypertension | 10,020,772 | null | null | 10020772 | 38341003 | 10,020,772 | 38,341,003 |
TAC2017_ADR | NORTHERA.xml_AR2.N1 | hyperpyrexia | 10,020,741 | null | null | 10020741 | 409702008 | 10,020,741 | 409,702,008 |
TAC2017_ADR | NORTHERA.xml_AR3.N1 | confusion | 10,010,305 | null | null | 10016322 10025482 10013082 10010305 10001854 10012373 | 213257006 367391008 40917007 | 10,010,305 | 40,917,007 |
TAC2017_ADR | NORTHERA.xml_AR4.N1 | exacerbate ischemic heart disease | 10,028,600 | null | null | 10028600 | 414795007 | 10,028,600 | 414,795,007 |
TAC2017_ADR | NORTHERA.xml_AR5.N1 | exacerbate arrhythmias | 10,003,119 | null | null | 10003119 | 698247007 | 10,003,119 | 698,247,007 |
TAC2017_ADR | NORTHERA.xml_AR6.N1 | exacerbate congestive heart failure | 10,007,559 | null | null | 10007559 | 42343007 | 10,007,559 | 42,343,007 |
TAC2017_ADR | NORTHERA.xml_AR7.N1 | headache | 10,019,211 | null | null | 10019211 | 25064002 | 10,019,211 | 25,064,002 |
TAC2017_ADR | NORTHERA.xml_AR8.N1 | dizziness | 10,013,573 | null | null | 10013573 | 404640003 271789005 | 10,013,573 | 404,640,003 |
TAC2017_ADR | NORTHERA.xml_AR9.N1 | nausea | 10,028,813 | null | null | 10028813 | 422587007 | 10,028,813 | 422,587,007 |
TAC2017_ADR | NORTHERA.xml_AR10.N1 | hypertension | 10,020,772 | null | null | 10020772 | 38341003 | 10,020,772 | 38,341,003 |
TAC2017_ADR | NORTHERA.xml_AR11.N1 | fatigue | 10,016,256 | null | null | 10016256 10003549 | 248274002 84229001 13791008 | 10,016,256 | 84,229,001 |
TAC2017_ADR | NORTHERA.xml_AR12.N1 | increased blood pressure | 10,005,750 | null | null | 10005750 | 24184005 | 10,005,750 | 24,184,005 |
TAC2017_ADR | NORTHERA.xml_AR13.N1 | falls | 10,016,173 | null | null | 10016173 | 161898004 | 10,016,173 | 161,898,004 |
TAC2017_ADR | NORTHERA.xml_AR14.N1 | urinary tract infections | 10,046,571 | null | null | 10046571 | 68566005 | 10,046,571 | 68,566,005 |
TAC2017_ADR | NORTHERA.xml_AR15.N1 | syncope | 10,042,772 | null | null | 10024855 10042772 | 271594007 272030005 309585006 418107008 | 10,042,772 | 271,594,007 |
TAC2017_ADR | NORTHERA.xml_AR16.N1 | cardiovascular risk | 10,075,534 | null | null | 10075534 | 267037003 | 10,075,534 | 267,037,003 |
TAC2017_ADR | NORTHERA.xml_AR17.N1 | allergic reactions | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | NORTHERA.xml_AR18.N1 | neuroleptic malignant syndrome | 10,029,282 | null | null | 10029282 | 15244003 | 10,029,282 | 15,244,003 |
TAC2017_ADR | NORTHERA.xml_AR19.N1 | nms | 10,029,282 | null | null | 10029282 | 15244003 | 10,029,282 | 15,244,003 |
TAC2017_ADR | NORTHERA.xml_AR20.N1 | fever | 10,037,660 | null | null | 10037660 10020843 10005911 | 386661006 | 10,037,660 | 386,661,006 |
TAC2017_ADR | NORTHERA.xml_AR21.N1 | hyperthermia | 10,020,843 | null | null | 10037660 10020843 10005911 | 386661006 | 10,020,843 | 386,661,006 |
TAC2017_ADR | NORTHERA.xml_AR22.N1 | muscle rigidity | 10,028,330 | null | null | 10052904 10028330 | 16046003 | 10,028,330 | 16,046,003 |
TAC2017_ADR | NORTHERA.xml_AR23.N1 | involuntary movements | 10,013,916 | null | null | 10013916 | 9748009 162227008 267078001 | 10,013,916 | 9,748,009 |
TAC2017_ADR | NORTHERA.xml_AR26.N1 | allergic-type reactions | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | NORTHERA.xml_AR27.N1 | bronchial asthma | 10,003,553 | null | null | 10003553 10066091 | 195967001 | 10,003,553 | 195,967,001 |